Among the 5612 subjects, DH was detected in 29 cases. The estimated prevalence of DH, as analyzed with sample weights, was 0.42% (95% CI, 0.26–0.67). The prevalences in the 19 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and 80+ age groups were 0.06% (95% CI, 0.01–0.46), 0%, 0.52% (95% CI, 0.18–1.54), 0.52% (95% CI, 0.19–1.42), 0.56% (95% CI, 0.27–1.15), 1.27% (95% CI, 0.60–2.66), and 2.09% (95% CI, 0.33–12.05), respectively (
Fig. 2;
Table 2). The prevalence of DH increased with age: 1.04-fold in 1 year, and 1.54-fold in 10 years, according to Poisson regression analysis (
P < 0.001). When different cut-off ages were applied, the prevalences of DH were 0.54% (95% CI, 0.34–0.75) in subjects aged 30 years and older, 0.67% (95% CI, 0.4–0.92) in those 40 years and older, 0.71% (95% CI, 0.42–1.01) in those 50 years and older, and 0.89% (95% CI, 0.48–1.31) in those 60 years and older (
Table 2). Glaucoma was diagnosed in 292 of the 5612 subjects, for an overall prevalence of 4.18% (95% CI, 3.58–4.88). Disc hemorrhage was found in 12 of those 292 glaucomatous subjects (2.82%; 95% CI, 1.53–5.14) and in 17 of the 5320 nonglaucomatous subjects (0.32%; 95% CI, 0.21–0.63). The prevalences of DH among glaucomatous subjects in the different age groups were 0%, 0%, 2.29% (95% CI, 0.32–14.54), 0%, 3.94% (95% CI, 1.47–10.18), 7.12% (95% CI, 3.05–15.73), and 0%, in the 19 to 29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and 80+ age groups, respectively (
Table 2). Over again, the prevalences of DH were 2.88% (95% CI, 1.54–5.33) in glaucomatous subjects aged 30 years and older, 3.25% (95% CI, 1.74–5.99) in those 40 years and older, 3.50% (95% CI, 1.83–6.59) in those 50 years and older, and 3.67% (95% CI, 1.95–7.02) in those 60 years and older. However, a Poisson regression analysis indicated that the prevalence DH in glaucomatous subjects did not increase with age (
P = 0.269).